Latest Articles

BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer - The Manila Times

BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer The Manila Times

Australia's Cartherics expands agreement with Catalent to focus on cancer and endometriosis treatment - BioSpectrum Asia

Australia's Cartherics expands agreement with Catalent to focus on cancer and endometriosis treatment BioSpectrum Asia

Natalie Githinji Moved to Tears by Fan’s Emotional Message on Her Digital Impact - Mpasho

Natalie Githinji Moved to Tears by Fan’s Emotional Message on Her Digital Impact Mpasho

Reply of the authors: Trial emulation and clinical trials.

USWNT boss Emma Hayes opens up on handling pressure and living with endometriosis - MSN

USWNT boss Emma Hayes opens up on handling pressure and living with endometriosis MSN

Atlantic Metal Roofing Launches Metal Specialist Division to Meet Surging Demand for Metal Roof Installation Across South Florida - The Manila Times

Atlantic Metal Roofing Launches Metal Specialist Division to Meet Surging Demand for Metal Roof Installation Across South Florida The Manila Times

Endometriosis: Why it takes an average of 8 Years to diagnose — and how to get answers faster - FemTech World

Endometriosis: Why it takes an average of 8 Years to diagnose — and how to get answers faster FemTech World

New AI femtech competition in Portugal aims to fast-track women’s health innovation - Tech.eu

New AI femtech competition in Portugal aims to fast-track women’s health innovation Tech.eu

Cartherics and Catalent Expand Commercial License Agreement - BioSpace

Cartherics and Catalent Expand Commercial License Agreement BioSpace

Epigenetic Compound Library Screen Identifies Ibrutinib as an Inhibitor of Ovarian Clear Cell Carcinoma Viability.

Ovarian clear cell carcinoma (OCCC) is an endometriosis-associated ovarian cancer subtype. Somatic mutations in OCCC are reported in ARID1A, PIK3CA, and the TERT promoter (TERTp), as well as less commonly …